News
Labcorp introduces US FDA approved blood test, Lumipulse pTau-217/Beta Amyloid 42 Ratio for Alzheimer's disease: Burlington, North Carolina Tuesday, August 19, 2025, 14:00 Hrs [IS ...
Accord BioPharma launches Imuldosa prefilled syringes at lowest WAC price among branded biosimilars to Stelara: Raleigh, North Carolina Tuesday, August 19, 2025, 13:00 Hrs [IST] A ...
WuXi Biologics Ireland facility receives EMA approval for commercial manufacturing of innovative biologic: Dundalk, Ireland Tuesday, August 19, 2025, 12:00 Hrs [IST] WuXi Biologic ...
Valneva’s chikungunya vaccine, Ixchiq receives Health Canada marketing authorization: Saint Herblain, France Tuesday, August 19, 2025, 10:00 Hrs [IST] Valneva SE, a specialty va ...
At its15th general body meeting recently, the Chennai-based Consortium of Indian Pharmaceutical Marketers and Manufacturers Associations (CIPMMA) passed a resolution urging the Union Health Ministry ...
US FDA grants breakthrough therapy designation to Daiichi Sankyo & Merck’s ifinatamab deruxtecan for patients with pretreated extensivestage SCLC: Tokyo Tuesday, August 19, 2025 ...
Shardul Nautiyal, Mumbai Tuesday, August 19, 2025, 08:00 Hrs [IST] ...
Shardul Nautiyal, Mumbai Tuesday, August 19, 2025, 08:00 Hrs [IST] ...
Future of Indian healthcare revolves around proactive, tech-driven & people-centric systems: Lovekesh Phasu: Nandita Vijayasimha, Bengaluru Tuesday, August 19, 2025, 08:00 Hrs [IS ...
Delhi DCA issues advisory to chemist associations on misuse of pregabalin & tapentadol formulations: Peethaambaran Kunnathoor, Chennai Tuesday, August 19, 2025, 08:00 Hrs [IST] In ...
Exports of drugs and pharmaceuticals from the country registered around 14 per cent growth in the month of July, while imports reported an increase of around 13.3 per cent compared to the same month ...
Caris Life Sciences demonstrates scientific rigor with clinical validation of US FDA approved MI Cancer Seek: Irving, Texas Monday, August 18, 2025, 16:00 Hrs [IST] Caris Life Sci ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results